Evidence map›Paper›PMID 42738876›Full record

ArticleCells2026

WNK1 Phosphorylation Sites in TBC1D1 and TBC1D4 Modulate Cell-Surface Abundance of GLUT1.

Andreia F A Henriques, Paulo Matos, Ana Sofia Carvalho, Mikel Azkargorta, Felix Elortza, Rune Matthiesen, Peter Jordan

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andreia F A HenriquesDepartment of Human Genetics, National Health Institute 'Dr. Ricardo Jorge', 1649-016 Lisbon, Portugal.ORCID 0000-0002-1631-7454
Paulo MatosDepartment of Human Genetics, National Health Institute 'Dr. Ricardo Jorge', 1649-016 Lisbon, Portugal.ORCID 0000-0002-9379-9696
Ana Sofia CarvalhoComputational and Experimental Biology Group, iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.ORCID 0000-0003-0657-1907
Mikel AzkargortaProteomics Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.
Felix ElortzaProteomics Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.ORCID 0000-0001-8839-5438
Rune MatthiesenComputational and Experimental Biology Group, iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.ORCID 0000-0002-6353-2616
Peter JordanDepartment of Human Genetics, National Health Institute 'Dr. Ricardo Jorge', 1649-016 Lisbon, Portugal.ORCID 0000-0002-1425-9211

Funding

Foundation for Science and Technology PTDC/SAU-MET/117236/2010Fundação para a Ciência e Tecnologia grant UID/MULTI/04046/2019Fundação para a Ciência e Tecnologia SFRH/BD/106080/2015
6 · The paper itself

Abstract

This manuscript is the corrected version of a previously published paper. Glucose uptake by mammalian cells is a key mechanism to maintain cell and tissue homeostasis and relies mostly on plasma membrane-localized glucose transporter proteins (GLUTs). Two main cellular mechanisms regulate GLUT proteins in the cell: first, expression of GLUT genes is under dynamic transcriptional control and is used by cancer cells to increase glucose availability. Second, GLUT proteins are regulated by membrane traffic from storage vesicles to the plasma membrane (PM). This latter process is triggered by signaling mechanisms and is well studied in the case of insulin-responsive cells, which activate protein kinase AKT to phosphorylate TBC1D4, a RAB-GTPase-activating protein involved in membrane traffic regulation. Previously, we identified protein kinase WNK1 as another kinase able to phosphorylate TBC1D4 and regulate the surface abundance of the constitutive glucose transporter GLUT1. Here we describe that downregulation of WNK1 through RNA interference in HEK293 cells led to a two-fold decrease in cell-surface GLUT1 abundance, concomitant with a 40% decrease in glucose uptake. By mass spectrometry, we identified serine (S) 704 in TBC1D4 and also S565 in its paralogue TBC1D1 as candidate WNK1 phosphorylation sites. Transfection of the respective phosphomimetic or unphosphorylatable TBC1D mutants into cells revealed that both affected the cell-surface abundance of GLUT1. The results reinforce a regulatory role for WNK1 in GLUT1 trafficking and glucose uptake and may have potential impact for the understanding of metabolic dysregulation, as observed in many cancer cells or insulin-responsive cell types.

Indexed as

Cell MembraneGlucose Transporter Type 1GTPase-Activating ProteinsWNK Lysine-Deficient Protein Kinase 1GlucoseHEK293 CellsHumansPhosphorylationGlucoseGlucose Transporter Type 1GTPase-Activating ProteinsSLC2A1 protein, humanTBC1D1 protein, humanTBC1D4 protein, humanWNK1 protein, humanWNK Lysine-Deficient Protein Kinase 1AKTglucose transportGLUT1membrane trafficprotein phosphorylationTBC1DWNK1

Identifiers

PMID42738876
PMCPMC13564549

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.